Financial Risks Of M&a Of SDJC Pharmaceutical Company Analysis And Prevention Research

With the continuous development of social economy,m&a plays an increasingly important role on the world economic stage.M&a is an important way for enterprises to grow and an important driving force to adjust the whole industrial structure.Stigler,a famous economist,once said that none of the world's famous large enterprises and groups developed entirely through internal accumulation,and almost all grew up through a variety of capital operation means such as acquisition or merger.Merger and acquisition is a kind of capital operation behavior,but it is also a kind of financial behavior,financial behavior will have a financial risk,so the financial risk throughout the whole in the process of the merger and acquisition of enterprises is an important factor decided to m&a success,is each enterprise of m&a behavior must face and solve.Under the influence of multiple factors such as the national attention to the people's livelihood and various policies and regulations to solve the people's livelihood,the reshuffle and integration of the pharmaceutical industry is an inevitable trend,so it is particularly important to study and control various financial risks in the merger wave of the pharmaceutical industry.To prevent the financial risk in the process of medical industry merger and acquisition,we should analyze and study the financial risk.This paper use the literature research,through reading a large number of literature theory of mergers and acquisitions at home and abroad and the study of the financial risk of m&a research and control on the list,and then to study m&a financial risk related content as the theoretical basis of this study,summarize SDJC pharmaceutical companies developing condition and using comparative analysis method to analyze its financial status and financial indicators,in order to deduce the may encounter in the process of mergers and acquisitions of financial risk.Taking SDJC pharmaceutical co.,LTD.'s acquisition of PG drug source as an example,this paper introduces in detail the background of the merger,the motivation of the merger,and the types of financial risks in the process of the merger,and proposes corresponding preventive and control measures according to the types of financial risks.Finally,this paper puts forward comprehensive Suggestions for the financial risks encountered in the mergers and acquisitions of the pharmaceutical industry,so as to provide reference for the future mergers and acquisitions of the pharmaceutical industry,and improve the financial risk control ability in the mergers and acquisitions of the pharmaceutical industry.